UNC lab partnership develops first COVID-19 treatment approved by FDA

Posted Nov 7, 2020
Remdesivir, a drug developed through a partnership between UNC’s Baric Lab and Gilead Sciences, was recently approved as a COVID-19 treatment. As of Oct. 22, remdesivir is the first and only FDA-approved COVID-19 treatment in the U.S. UNC faculty and students reflected on the significance of remdesivir’s approval and what this means for the University. (Daily Tar Heel)

Related: Campus Connections

10 things every UNC fan must do when visiting Chapel Hill
Locals call it Blue Heaven and it doesn’t take long to understand why. Virtually everything in town is painted the color of the sky. Even...
Fri Nov 15, 2024

Carolina Insider Podcast: UNC vs. Kansas Basketball Recap, Ryan McCollum Interview
North Carolina and Kansas battled in a terrific early-season college basketball game with the Tar Heels coming up just short. Jones Angell and Adam Lucas...
Tue Nov 12, 2024

The Military and UNC
During and before World War II, UNC cooperated with the military in projects such as the Navy preflight program which prepared stud students from North...
Mon Nov 11, 2024

Two Generations, One Legacy: Wes Durham Follows In Father’s Broadcasting Footsteps
Wes Durham vividly remembers his dad's voice booming over the elementary school intercom system in the middle of class one day in March. Durham was...
Sat Nov 9, 2024